title: Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.
authors.forename: Jacques
authors.initials: J
authors.lastname: Fellay
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Venetz
authors.forename: Manuel
authors.initials: M
authors.lastname: Pascual
authors.forename: John-David
authors.initials: JD
authors.lastname: Aubert
authors.forename: Charles
authors.initials: C
authors.lastname: Seudoux
authors.forename: Pascal R A
authors.initials: PR
authors.lastname: Meylan
mesh_terms: D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D015774:Ganciclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D016377:Organ Transplantation / Q000009:adverse effects*; D000077562:Valganciclovir
chemical_list: D000998:Antiviral Agents; D000077562:Valganciclovir; D015774:Ganciclovir